Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr 7;17(1):108.
doi: 10.1186/s12974-020-01785-6.

The role of Toll-like receptor signaling pathways in cerebrovascular disorders: the impact of spreading depolarization

Affiliations
Review

The role of Toll-like receptor signaling pathways in cerebrovascular disorders: the impact of spreading depolarization

Rezan Ashayeri Ahmadabad et al. J Neuroinflammation. .

Abstract

Cerebral vascular diseases (CVDs) are a group of disorders that affect the blood supply to the brain and lead to the reduction of oxygen and glucose supply to the neurons and the supporting cells. Spreading depolarization (SD), a propagating wave of neuroglial depolarization, occurs in different CVDs. A growing amount of evidence suggests that the inflammatory responses following hypoxic-ischemic insults and after SD plays a double-edged role in brain tissue injury and clinical outcome; a beneficial effect in the acute phase and a destructive role in the late phase. Toll-like receptors (TLRs) play a crucial role in the activation of inflammatory cascades and subsequent neuroprotective or harmful effects after CVDs and SD. Here, we review current data regarding the pathophysiological role of TLR signaling pathways in different CVDs and discuss the role of SD in the potentiation of the inflammatory cascade in CVDs through the modulation of TLRs.

Keywords: Brain; Chemokines; Inflammatory mediators; Spreading depolarization; Stroke; Subarachnoid hemorrhage; Toll-like receptors.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Schematic diagram of Toll-like receptor (TLRs) signaling pathways. TLRs are expressed in neurons, microglia, astrocytes, oligodendrocytes, and neural stem cells. LPS, lipopolysaccharide; LRR, leucine-rich repeat; dsDNA, double-stranded DNA; dsRNA, double-stranded RNA; ssRNA, single-stranded RNA; TIR, toll/IL1 receptor; IRF, interferon regulatory factor; MyD88, myeloid differentiation primary response 88; TRIF, TIR-domain-containing adapter inducing IFN-β; IFN, interferon

References

    1. Rajendran P, Rengarajan T, Thangavel J, Nishigaki Y, Sakthisekaran D, Sethi G, et al. The vascular endothelium and human diseases. Int J Biol Sci. 2013;9:1057. doi: 10.7150/ijbs.7502. - DOI - PMC - PubMed
    1. Tsze DS, Valente JH. Pediatric stroke: a review. Emergency Medicine International. 2011;2011:734506. doi: 10.1155/2011/734506. - DOI - PMC - PubMed
    1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367:1747–1757. doi: 10.1016/S0140-6736(06)68770-9. - DOI - PubMed
    1. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (dalys) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380:2197–2223. doi: 10.1016/S0140-6736(12)61689-4. - DOI - PubMed
    1. Hartmann G, Tschöp M, Fischer R, Bidlingmaier C, Riepl R, Tschöp K, et al. High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and c-reactive protein. Cytokine. 2000;12:246–252. doi: 10.1006/cyto.1999.0533. - DOI - PubMed

MeSH terms

Substances

LinkOut - more resources